ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/10/20 | 1,989 | 2,017 | 1,982 | 2,008 | -1 | ±0% | 121,200 |
2023/10/19 | 2,018 | 2,040 | 2,009 | 2,009 | -33 | -1.6% | 102,200 |
2023/10/18 | 2,025 | 2,050 | 2,003 | 2,042 | +22 | +1.1% | 102,500 |
2023/10/17 | 2,021 | 2,045 | 2,015 | 2,020 | -22 | -1.1% | 156,300 |
2023/10/16 | 2,058 | 2,060 | 2,021 | 2,042 | -16 | -0.8% | 75,900 |
2023/10/13 | 2,094 | 2,094 | 2,056 | 2,058 | -56 | -2.6% | 98,400 |
2023/10/12 | 2,123 | 2,135 | 2,111 | 2,114 | -6 | -0.3% | 58,400 |
2023/10/11 | 2,144 | 2,150 | 2,120 | 2,120 | -24 | -1.1% | 52,200 |
2023/10/10 | 2,117 | 2,152 | 2,112 | 2,144 | +7 | +0.3% | 126,300 |
2023/10/06 | 2,116 | 2,158 | 2,113 | 2,137 | +40 | +1.9% | 117,500 |
2023/10/05 | 2,081 | 2,108 | 2,077 | 2,097 | -4 | -0.2% | 162,900 |
2023/10/04 | 2,110 | 2,142 | 2,073 | 2,101 | -18 | -0.8% | 102,900 |
2023/10/03 | 2,170 | 2,179 | 2,119 | 2,119 | -55 | -2.5% | 116,000 |
2023/10/02 | 2,202 | 2,228 | 2,174 | 2,174 | -45 | -2% | 135,400 |
2023/09/29 | 2,235 | 2,235 | 2,205 | 2,219 | -20 | -0.9% | 100,200 |
2023/09/28 | 2,255 | 2,273 | 2,223 | 2,239 | -66 | -2.9% | 121,700 |
2023/09/27 | 2,270 | 2,306 | 2,252 | 2,305 | +47 | +2.1% | 228,400 |
2023/09/26 | 2,278 | 2,287 | 2,254 | 2,258 | -46 | -2% | 166,800 |
2023/09/25 | 2,272 | 2,306 | 2,265 | 2,304 | +33 | +1.5% | 135,000 |
2023/09/22 | 2,282 | 2,299 | 2,260 | 2,271 | -31 | -1.3% | 115,000 |
2023/09/21 | 2,330 | 2,331 | 2,297 | 2,302 | -18 | -0.8% | 91,100 |
2023/09/20 | 2,363 | 2,380 | 2,320 | 2,320 | -52 | -2.2% | 114,600 |
2023/09/19 | 2,378 | 2,388 | 2,354 | 2,372 | -26 | -1.1% | 127,900 |
2023/09/15 | 2,247 | 2,400 | 2,247 | 2,398 | +1 | ±0% | 235,900 |
2023/09/14 | 2,400 | 2,405 | 2,391 | 2,397 | -24 | -1% | 110,600 |
2023/09/13 | 2,407 | 2,428 | 2,389 | 2,421 | -11 | -0.5% | 102,900 |
2023/09/12 | 2,381 | 2,432 | 2,381 | 2,432 | +36 | +1.5% | 132,000 |
2023/09/11 | 2,377 | 2,406 | 2,367 | 2,396 | +13 | +0.5% | 64,200 |
2023/09/08 | 2,400 | 2,412 | 2,372 | 2,383 | -36 | -1.5% | 67,100 |
2023/09/07 | 2,437 | 2,441 | 2,415 | 2,419 | -19 | -0.8% | 64,800 |
2023/09/06 | 2,465 | 2,465 | 2,419 | 2,438 | -30 | -1.2% | 69,400 |
2023/09/05 | 2,438 | 2,469 | 2,428 | 2,468 | +36 | +1.5% | 58,400 |
2023/09/04 | 2,431 | 2,444 | 2,422 | 2,432 | +8 | +0.3% | 58,200 |
2023/09/01 | 2,422 | 2,447 | 2,415 | 2,424 | +8 | +0.3% | 55,700 |
2023/08/31 | 2,407 | 2,428 | 2,407 | 2,416 | -2 | -0.1% | 45,700 |
2023/08/30 | 2,410 | 2,420 | 2,400 | 2,418 | +8 | +0.3% | 36,400 |
2023/08/29 | 2,418 | 2,418 | 2,397 | 2,410 | +4 | +0.2% | 20,500 |
2023/08/28 | 2,399 | 2,410 | 2,393 | 2,406 | +27 | +1.1% | 21,400 |
2023/08/25 | 2,369 | 2,386 | 2,366 | 2,379 | +5 | +0.2% | 22,100 |
2023/08/24 | 2,360 | 2,382 | 2,360 | 2,374 | +7 | +0.3% | 21,400 |
2023/08/23 | 2,347 | 2,370 | 2,346 | 2,367 | +1 | ±0% | 20,900 |
2023/08/22 | 2,343 | 2,366 | 2,333 | 2,366 | +28 | +1.2% | 23,600 |
2023/08/21 | 2,353 | 2,370 | 2,338 | 2,338 | +1 | ±0% | 27,300 |
2023/08/18 | 2,315 | 2,358 | 2,312 | 2,337 | -3 | -0.1% | 56,400 |
2023/08/17 | 2,367 | 2,378 | 2,326 | 2,340 | -49 | -2.1% | 50,100 |
2023/08/16 | 2,389 | 2,398 | 2,375 | 2,389 | -24 | -1% | 35,800 |
2023/08/15 | 2,413 | 2,428 | 2,399 | 2,413 | -11 | -0.5% | 56,300 |
2023/08/14 | 2,452 | 2,471 | 2,422 | 2,424 | -17 | -0.7% | 32,400 |
2023/08/10 | 2,418 | 2,441 | 2,405 | 2,441 | +29 | +1.2% | 26,900 |
2023/08/09 | 2,400 | 2,416 | 2,380 | 2,412 | +17 | +0.7% | 37,500 |
451~
500
件表示中 / 3769件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 206,000円 | +3.1% | -6.5% | 2.33% | 9.56倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 274,000円 | +21.7% | +999.9% | 0.00% | 12.62倍 | 4.32倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 318,500円 | +5.1% | -7.0% | 2.51% | 20.91倍 | 0.86倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 154,600円 | -2.4% | -52.3% | 3.69% | 18.50倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 238,900円 | +4.1% | -3.1% | 2.43% | 20.75倍 | 1.81倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム